Size: px
Start display at page:

Download ""

Transcription

1 C M Y CM MY CY CMY K Co nf e r e nc e D e t a il s 8

2 6 th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease 5-7 March 2009 Granada Spain Granada Congress & Exhibition Centre Supported by Novartis Pharmaceutical Corporation and Ipsen Beaufour

3 Welcome to Granada The ENETS Executive Committee extends a warm welcome to its 6th Annual Conference in Granada, Spain. In attending this meeting, you join some of the most respected and dynamic researchers and key opinion leaders in the field of neuroendocrine tumor research. Over the next two days, they will be detailing the most relevant and significant advances in the field today. Our aim is to give you beneficial lessons to help you in your daily clinical practice. On behalf of the scientific organizing committee, I welcome you to Granada. The city is a highly appropriate place to hold our conference: its legacy of blended cultures mirrors our Society s mission in fostering international cooperation toward solving the complex clinical problems neuroendocrine tumors present. The Society today claims more than 550 members, hailing from 48 countries this is a proud achievement for a research society dedicated to a rare disease, and one founded only five years ago. Again, I welcome all participants to our annual meeting and appreciate the distances traveled to be here. Our 2008 conference in Paris received very positive reviews and we hope that the Granada meeting will be just as rewarding. In inviting the conference lecturers, we hope to exhibit the Society s work of this past year, including the ENETS Guidelines for the Standards of Care. But we also felt it important to add some new aspects to the program. This would encompass poorly differentiated endocrine carcinomas, novel approaches to NET treatment, and a session on combined therapy and clinical trials. We also have expanded the program to include an additional session for clinical research abstracts. I am exceptionally proud to announce that we received 119 abstracts for the meeting. The growth in NET research, as well as the continued increase in membership registrations and abstract submissions, speaks for itself and our future work in the field. The ENETS Annual Conference this year is sponsored by the pharmaceutical firms Novartis, as platinum sponsor, and Ipsen, as silver sponsor. I would like to take this opportunity to thank both for their continued support for and interest in ENETS. I would also like to thank the companies CISBIO, Covidien, ITG Isotope Technologies Garching and Sirtex, which are exhibiting during the conference. I welcome each of you to Granada and to the ENETS 6th Annual Conference. Guido Rindi, M.D., Ph.D. Parma, Italy Chairman, European Neuroendocrine Tumor Society (ENETS) 2

4 Saturday, 7 March :30-09:30 SESSION 5: Liver Metastases Chairs: D. O Toole, Dublin, IRL D. J. Kwekkeboom, Rotterdam, NED 08:30-08:50 Key Players in Metastases Development D. R. Welch, Birmingham, AL, 08:50-09:10 Surgery and Ablation T. Steinmüller, Berlin, 09:10-09:30 Medical Treatment K. Öberg, Uppsala, 09:30-10:15 SELECTED ABSTRACTS (III): Basic/Translational Research Chairs: M. Caplin, London, U.-F. Pape, Berlin, 09:30-09:45 Molecular predictors of response to chemotherapy in advanced/metastatic gastroenteropancreatic endocrine tumors A. Couvelard, Clichy, 09:45-10:00 Adenosine A2 receptor signalling mediates chromogranin A secretion from neuroendocrine tumors A. Kalhan, Cardiff, 10:00-10:15 Dual expression of alpha-internexin in pancreatic endocrine tumors and its implications M. Mei, Beijing, CHN 10:15-10:45 COFFEE BREAK 10:45-11:00 Young Investigator Awards G. Kaltsas, Athens, GRE G. Rindi, Parma, 11:00-12:30 SESSION 6: Combined Therapy and Clinical Trials Chairs: B. Kos-Kud a, Zabrze, POL M. Kulke, Boston, MA, 11:00-11:30 Hot-Off-the-Press Results of Ongoing Trials in the EU and the C. Lombard-Bohas, Lyon, J. Yao, Houston, TX, 11:30-12:00 Single or Monotherapy: Need for Combinations? L. Kvols, Tampa, FL, 12:00-12:30 Basic Evidence for Future Trials E. Van Cutsem, Leuven, BEL 12:30-12:50 Lessons from Granada R. Jensen, Bethesda, MD, 12:50-13:00 Concluding Remarks G. Rindi, Parma, END OF MEETING Mark Your Calendars Now! 7 th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumors For more information, visit: March 2010 Berlin Germany Session 5 Abstracts 3 Session 6 6th Annual ENETS Conference 7 March

5 C Y CM MY CY CMY K Conference organization: Scientific organizing committee: ENETS Coordinating Office c/o Charité - University Hospital Campus Virchow-Klinikum Hepatology and Gastroenterology Augustenburger Platz Berlin, Germany Martyn Caplin London Wouter de Herder Rotterdam NED Barbro Eriksson Uppsala Dermot O Toole Dublin IRL tel +49 (0) / fax +49 (0) Guido Rindi Parma Philippe Ruszniewski Clichy Bertram Wiedenmann Berlin office@neuroendocrine.net 4 M

6 Friday, 6 March :30-10:30 SESSION 2: Various localizations, various problems Chairs: W. de Herder, Rotterdam, NED G. Delle Fave, Rome, 08:30-09:00 Lung E. Baudin, Villejuif, 09:00-09:30 Pancreas M. Mallath, Mumbai, IND 09:30-10:00 Rectum J. Ramage, Basingstoke, 10:00-10:30 Ileum F. Costa, Sao Paulo, BRA 10:30-11:00 ENETS Life Achievement Award Chair: G. Rindi, Parma, Recipient: R. Arnold, Marburg/Munich, Dedication: B. Wiedenmann, Berlin, 11:00-11:30 COFFEE BREAK 11:30-12:30 SESSION 3: Poorly Differentiated Endocrine Carcinomas Chairs: L. Kvols, Tampa, FL, ; P. Komminoth, Zürich, SUI 11:30-11:50 Diagnosis O. Nilsson, Gothenborg, 11:50-12:10 Therapy and Management (I): Surgery H. Ahlman, Gothenborg, 12:10-12:30 Therapy and Management (II): Medical Treatment J. Yao, Houston, TX, 12:30-14:00 LUNCH 14:00-15:15 SELECTED ABSTRACTS (II): Clinical Research Chairs: R. V. Thakker, Oxford, D. Ferone, Genoa, 14:00-14:15 Prevalence and features of MEN1 in a large cohort of gastroenteropancreatic and thoracic NET: data from a large multicentric Italian database P. Ferolla, Perugia, 14:15-14:30 Clinical results of PRRT with 90 Y-DOTATATE and 90 Y/ 177 Lu- DOTATATE - what is better for therapy? L. Krolicki, Warsaw, POL 14:30-14:45 Chemotherapy with 5-Fluorouracil, cisplatin and streptozocin (FCiSt) for neuroendocrine tumors T. Meyer, London, 14:45-15:00 Placebo-controlled, double-blind, prospective, randomized study on the effect of Octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group A. Rinke, Marburg, 15:00-15:15 First line treatment of metastatic pancreatic endocrine carcinomas with capecitabine and temozolomide J. Strosberg, Tampa, FL, 15:15-16:15 SESSION 4: Surgery, Established Techniques and Novel Approaches Chairs: R. Kianmanesh, Colombes, B. Eriksson, Uppsala, 15:15-15:35 Lung E. Lim, London, 15:35-15:55 Gut I. Modlin, New Haven, CT, 15:55-16:15 Pancreas A. Sauvanet, Clichy, 16:15-17:00 Poster Viewing 17:00 SATELLITE SYMPOSIA Session 3 Session 2 Abstracts 2 Session 4 6th Annual ENETS Conference 6 March

7 C M Y CM MY CY CMY K SESSION PARTICIPANTS H. Ahlman, Gothenborg G. Åkerström, Gothenborg R. Arnold, Munich E. Baudin, Villejuif M. Caplin, London F. Costa, Sao Paulo W. de Herder, Rotterdam G. Delle Fave, Rome B. Eriksson, Uppsala D. Ferone, Genoa A. Grossman, London R. Jensen, Bethesda, MD G. Kaltsas, Athens R. Kianmanesh, Colombes P. Komminoth, Zürich B. Kos-Kud a, Zabrze M. Kulke, Boston, MA L. Kvols, Tampa, FL D. Kwekkeboom, Rotterdam E. Lim, London BRA NED GRE SUI POL NED C. Lombard-Bohas, Lyon M. Mallath, Mumbai I. Modlin, New Haven, CT O. Nilsson, Gothenborg K. Öberg, Uppsala D. O Toole, Dublin U.-F. Pape, Berlin U. Plöckinger, Berlin J. Ramage, Basingstoke G. Rindi, Parma P. Ruszniewski, Clichy H. Sasano, Sendai A. Sauvanet, Clichy T. Steinmüller, Berlin R. V. Thakker, Oxford E. Van Cutsem, Leuven D. R. Welch, Birmingham, AL B. Wiedenmann, Berlin J. Yao, Houston, TX IND IRL JAP BEL J. Ardill, Belfast A. Astudillo, Oviedo R. Bettini, Verona P. Brown, The Woodlands, TX ESP A. Couvelard, Clichy A. Kalhan, Cardiff L. Krolicki, Warsaw M. Mei, Beijing T. Meyer, London A. Rinke, Marburg J. Strosberg, Tampa, FL POL CHN ABSTRACT PRESENTERS A. Falchetti, Florence P. Ferolla, Perugia 6

8 ADVANCE REGISTRATION: Wednesday, 4 March 2009, 16:00 18:00 Conference participants can register the evening before the conference begins in the entrance lobby of the Granada Congress & Exhibition Centre. Thursday, 5 March :00-13:00 REGISTRATION 13:00-13:20 Welcome and Introduction G. Rindi, ENETS Chairman, Parma, 13:20-14:30 SESSION 1: Standards of Care Chairs: U. Plöckinger, Berlin, A. Grossman, London, 13:20-13:35 Introduction U. Plöckinger, Berlin, 13:35-13:55 Diagnosis B. Eriksson, Uppsala, 13:55-14:15 Medical Therapy P. Ruszniewski, Clichy, 14:15-14:30 Surgical Therapy G. Åkerström, Gothenborg, 14:30-15:00 COFFEE BREAK 15:00-16:15 Selected Abstracts (I): Clinical Research Chairs: G. Kaltsas, Athens, GRE H. Sasano, Sendai, JAP 15:00-15:15 Assessment of the sensitivity of circulating neurokinin A and chromogranin A to changing prognosis in patients with serotoninproducing endocrine tumors of the ileum and colon J. Ardill, Belfast, 15:15-15:30 Snail as epithelial-mesenchymal transition marker in neuroendocrine tumors of the lung A. Astudillo, Oviedo, ESP 15:30-15:45 Non-functioning pancreatic endocrine tumors: Any correlation of tumor size with malignancy? R. Bettini, Verona, 15:45-16:00 LX1032: A novel approach for managing gastrointestinal symptoms in carcinoid syndrome P. Brown, The Woodlands, TX, 16:00-16:15 Early identification of the MEN1-associated gastrinomas: Use of the secretin test in the experience of the Center for Hereditary Endocrine Tumors of Florence, Italy A. Falchetti, Florence, 16:15-17:15 Poster Viewing 17:15-18:15 ENETS General Assembly 18:15 WELCOME RECEPTION Session 1 Abstracts I 6th Annual ENETS Conference 5 March

A Newsletter for Medical Professionals and ENETS Members

A Newsletter for Medical Professionals and ENETS Members A Newsletter for Medical Professionals and ENETS Members Summer 2009 The European Neuroendocrine Tumor Society (ENETS) Executive Committee: Chairman: Guido Rindi, Parma, Italy Vice-Chairman: Wouter de

More information

10 th Annual ENETS Conference

10 th Annual ENETS Conference 10 th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease 6-8 March 2013 Barcelona P R E L I M I N A R Y P R O G R A M 1 Scientific Organizing Committee Martyn Caplin,

More information

Preliminary Conference Program

Preliminary Conference Program Preliminary Conference Program Contents Scientific Organizing Committee... 1 ENETS Scientific Conference Program... 2 09.03.2016... 2 ENETS Postgraduate Course... 2 Welcome Reception... 3 10.03.2016...

More information

ENETS Consensus Guidelines for the Standard of Care in

ENETS Consensus Guidelines for the Standard of Care in Neuroendocrinology (DOI:10.1159/000457957) (Accepted, unedited article not yet assigned to an issue) Advanced Release: February 11, 2017 2017 S. Karger AG, Basel www.karger.com/nen Received: December 12,

More information

A Newsletter for Medical Professionals and ENETS Members

A Newsletter for Medical Professionals and ENETS Members Spring/Summer 2007 The European Neuroendocrine Tumor Society (ENETS) Executive Committee: Chairman: Wouter de Herder, Rotterdam, The Netherlands Vice-Chairman: Bertram Wiedenmann, Berlin, Germany Treasurer:

More information

A Newsletter for Medical Professionals and ENETS Members

A Newsletter for Medical Professionals and ENETS Members Spring/Summer 2010 The European Neuroendocrine Tumor Society (ENETS) Executive Committee: Chairman: Philippe Ruszniewski, Clichy, France Vice-Chairman: Guido Rindi, Rome, Italy Chairman-Elect: Kjell Öberg,

More information

Preliminary Conference Program

Preliminary Conference Program Preliminary Conference Program Table of Contents ENETS Scientific Conference Program... 4 09.03.2016... 4 ENETS Postgraduate Course... 4 Welcome Reception... 5 10.03.2016... 6 Meet the Professor... 6 Welcome

More information

CLICK TO GO BACK TO KIOSK MENU

CLICK TO GO BACK TO KIOSK MENU Clinical outcomes in patients with baseline renal dysfunction in the NETTER- Study: 77 Lu-DOTATATE vs. high dose octreotide in progressive midgut neuroendocrine tumors J. Strosberg, E. Wolin 2, B. Chasen

More information

Review of Gastrointestinal Carcinoid Tumors: Latest Therapies

Review of Gastrointestinal Carcinoid Tumors: Latest Therapies Review of Gastrointestinal Carcinoid Tumors: Latest Therapies Arvind Dasari, MD, MS Department of Gastrointestinal Medical Oncology The University of Texas MD Anderson Cancer Center Houston, TX, USA Neuroendocrine

More information

MEDICAL MANAGEMENT OF METASTATIC GEP-NET

MEDICAL MANAGEMENT OF METASTATIC GEP-NET MEDICAL MANAGEMENT OF METASTATIC GEP-NET Jeremy Kortmansky, MD Associate Professor of Clinical Medicine Yale Cancer Center DISCLOSURES: NONE Introduction Gastrointestinal and pancreatic neuroendocrine

More information

ISRAELI NEUROENDOCRINE TUMORS PROGRAM

ISRAELI NEUROENDOCRINE TUMORS PROGRAM th THE 4 1 ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 11.10.2018-13.10.2018 Crown Plaza Hotel, the Dead Sea PROGRAM Thursday, 11.10.2018 15:00-15:30 Registration 15:30-15:50 Opening Remarks 15:50-16:50

More information

Toward More Aggressive Management of Neuroendocrine Tumors: Current and Future Perspectives

Toward More Aggressive Management of Neuroendocrine Tumors: Current and Future Perspectives Toward More Aggressive Management of Neuroendocrine Tumors: Current and Future Perspectives Moderator: Ashley Grossman, MD, FRCP Professor of Neuroendocrinology William Harvey Research Institute Barts

More information

Recent developments of oncology in neuroendocrine tumors (NETs)

Recent developments of oncology in neuroendocrine tumors (NETs) Recent developments of oncology in neuroendocrine tumors (NETs) Marc Peeters MD, PhD Coordinator Multidisciplinary Oncological Center Antwerpen (MOCA) Head of the Oncology Department UZA, Professor in

More information

Cutting Edge Treatment of Neuroendocrine Tumors

Cutting Edge Treatment of Neuroendocrine Tumors Cutting Edge Treatment of Neuroendocrine Tumors Daneng Li, MD Assistant Clinical Professor Department of Medical Oncology & Therapeutics Research City of Hope Click to edit Master Presentation Date DISCLOSURE

More information

TRACTAMENT ONCOLÒGIC DELS TUMORS NEUROENDOCRINS METASTÀSICS

TRACTAMENT ONCOLÒGIC DELS TUMORS NEUROENDOCRINS METASTÀSICS TRACTAMENT ONCOLÒGIC DELS TUMORS NEUROENDOCRINS METASTÀSICS Jaume Capdevila Unitat de Tumors GI i Endocrins Hospital Universitari Vall d Hebron Barcelona Experts, acollidors i solidaris OUTLINE BACKGROUND

More information

Updates in Pancreatic Neuroendocrine Carcinoma Highlights from the 2010 ASCO Annual Meeting. Chicago, IL, USA. June 4-8, 2010

Updates in Pancreatic Neuroendocrine Carcinoma Highlights from the 2010 ASCO Annual Meeting. Chicago, IL, USA. June 4-8, 2010 HIGHLIGHT ARTICLE Updates in Pancreatic Neuroendocrine Carcinoma Highlights from the 2010 ASCO Annual Meeting. Chicago, IL, USA. June 4-8, 2010 Susan Alsamarai 1, Steven K Libutti 2, Muhammad Wasif Saif

More information

Cutting Edge Treatment of Neuroendocrine Tumors

Cutting Edge Treatment of Neuroendocrine Tumors Cutting Edge Treatment of Neuroendocrine Tumors Daneng Li, MD Assistant Clinical Professor Department of Medical Oncology & Therapeutics Research City of Hope Click to edit Master Presentation Date DISCLOSURE

More information

A Newsletter for Medical Professionals and ENETS Members

A Newsletter for Medical Professionals and ENETS Members A Newsletter for Medical Professionals and ENETS Members Summer/Fall 2013 The European Neuroendocrine Tumor Society (ENETS) Executive Committee: Chairman: Kjell Öberg, Uppsala, Sweden Vice-Chairman: Philippe

More information

NICaN Pancreatic Neuroendocrine Tumour SACT protocols. 1.0 Dr M Eatock Final version issued

NICaN Pancreatic Neuroendocrine Tumour SACT protocols. 1.0 Dr M Eatock Final version issued Reference No: Title: Author(s) Systemic Anti-Cancer Therapy (SACT) Guidelines for Pancreatic Neuro-endocrine Tumours Dr Martin Eatock, Consultant Medical Oncologist & on behalf of the GI Oncologists Group,

More information

ISRAELI NEUROENDOCRINE TUMORS PROGRAM

ISRAELI NEUROENDOCRINE TUMORS PROGRAM 1 rd THE 3 ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 22.09.2016-24.09.2016 Crown Plaza Hotel, The Dead Sea PROGRAM Thursday, 22.09.2016 15:00-15:30 Registration 15:30-15:50 Opening Remarks 15:50-16:50

More information

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas

ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas ENETS Consensus Guidelines Published online: January 5, 2016 ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas R. Garcia-Carbonero a H.

More information

Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors

Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors Gastrointestinal Neuroendocrine Tumors: A Closer Look at the Characteristics of These Diverse Tumors Jaume Capdevila, MD, PhD Vall d'hebron University Hospital Vall d'hebron Institute of Oncology (VHIO)

More information

Crown Plaza Hotel, the Dead Sea PROGRAM

Crown Plaza Hotel, the Dead Sea PROGRAM 1 THE 4 th ISRAELI NEUROENDOCRINE TUMORS (INET) CONGRESS 11.10.2018-13.10.2018 Crown Plaza Hotel, the Dead Sea PROGRAM Thursday, 11.10.2018 15:00-15:30 Registration 15:30-15:50 Opening Remarks: Dr. Simona

More information

Teresa Alonso Gordoa Servicio Oncología Médica Hospital Universitario Ramón y Cajal

Teresa Alonso Gordoa Servicio Oncología Médica Hospital Universitario Ramón y Cajal Teresa Alonso Gordoa Servicio Oncología Médica Hospital Universitario Ramón y Cajal Incidence per 100,000 EPIDEMIOLOGY Incidence rates of neuroendocrine tumors by primary tumor site 1.4 1.2 1.0 0.8 0.6

More information

ENETS Aims & Key Dates... 5 Welcome Letter from the ENETS Chairman... 7 EACCME - UEMS Accreditation Statement

ENETS Aims & Key Dates... 5 Welcome Letter from the ENETS Chairman... 7 EACCME - UEMS Accreditation Statement XXXXXXXXX XXXXXXXX 2 Footnotes Table of Contents ENETS Aims & Key Dates... 5 Welcome Letter from the ENETS Chairman... 7 EACCME - UEMS Accreditation Statement 2017... 9 INTRODUCTION General Information...

More information

ENETS Consensus Guidelines. Neuroendocrinology 2016;103: DOI: /

ENETS Consensus Guidelines. Neuroendocrinology 2016;103: DOI: / Consensus Guidelines Published online: January 5, 2016 Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and

More information

Color Codes Pathology and Genetics Medicine and Clinical Pathology Surgery Imaging

Color Codes Pathology and Genetics Medicine and Clinical Pathology Surgery Imaging Saturday, November 5, 2005 8:30-10:30 a. m. Poorly Differentiated Endocrine Carcinomas Chairman: E. Van Cutsem, Leuven, Belgium 9:00-9:30 a. m. Working Group Sessions Pathology and Genetics Group leaders:

More information

for the Diagnosis and Treatment of Neuroendocrine Tumor Disease 6-8 March 2019 Barcelona Spain

for the Diagnosis and Treatment of Neuroendocrine Tumor Disease 6-8 March 2019 Barcelona Spain 16th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease 6-8 March 2019 Barcelona Spain PRELIMINARY SCIENTIFIC PROGRAM Scientific Organizing Committee 2 Anne Couvelard

More information

*Bert Bakker was an employee of Novartis Pharmaceuticals Corporation until June 06, 2014.

*Bert Bakker was an employee of Novartis Pharmaceuticals Corporation until June 06, 2014. Page 1 of 20 Accepted Preprint first posted on 15 September 2015 as Manuscript ERC-15-0314 1 2 Efficacy of Octreotide LAR in Neuroendocrine Tumors: RADIANT-2 Placebo Arm Post Hoc Analysis 3 4 Authors:

More information

2015: Year in Review Results of Recent Trials

2015: Year in Review Results of Recent Trials 2015: Year in Review Results of Recent Trials Pamela L. Kunz, MD Assistant Professor of Medicine / GI Oncology Director, Stanford NET Program Stanford University School of Medicine Disclosures Research

More information

3. ITLT Essen 2013 Interdisciplinary Treatment of Liver Tumors April 18-20, 2013 Essen, Germany

3. ITLT Essen 2013 Interdisciplinary Treatment of Liver Tumors April 18-20, 2013 Essen, Germany 3. ITLT Essen 2013 Interdisciplinary Treatment of Liver Tumors April 18-20, 2013 Essen, Germany Scientific Program Thursday, 18th April 2013 HR Thursday, 18th April 08:00 Breakfast Symposia 09:00 Registration

More information

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms

ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms Consensus Guidelines Published online: January 5, 2016 Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms J.K. Ramage a W.W. De Herder b G. Delle Fave c P. Ferolla d D. Ferone e T. Ito

More information

Consensus guidelines for high grade gastro entero pancreatic (GEP) neuroendocrine tumours and neuroendocrine carcinomas (NEC)

Consensus guidelines for high grade gastro entero pancreatic (GEP) neuroendocrine tumours and neuroendocrine carcinomas (NEC) Neuroendocrinology (DOI:10.1159/000443172) (Accepted, unedited article not yet assigned to an issue) Advanced Release: January 5, 2016 2016 S. Karger AG, Basel www.karger.com/nen Received: Accepted after

More information

Letter from the Chairman (Dermot O Toole)

Letter from the Chairman (Dermot O Toole) Letter from the Chairman (Dermot O Toole) Dear Friends and Colleagues, Prof. Dermot O Toole, ENETS Chairman It is a great honour to have tak en over the role as Chairman of ENETS at our last annual meeting

More information

Diagnosis and workup of 522 consecutive patients with neuroendocrine neoplasms in Switzerland

Diagnosis and workup of 522 consecutive patients with neuroendocrine neoplasms in Switzerland Published 19 February 2014, doi:10.4414/smw.2014.13924 Cite this as: Diagnosis and workup of 522 consecutive patients with neuroendocrine neoplasms in Switzerland Marine Gouffon a, Samuel Iff b, Katrin

More information

5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition

5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition 5th World Congress of Pediatric Gastroenterology, Hepatology and Nutrition SIXTH DRAFT OF THE PROGRAM AUGUST 28, 2014 Wednesday, October 5, 2016 08:00-16:30 Post Graduate course (To be developed by the

More information

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours

Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours Ulrich-Frank Pape 1 *, Uta Berndt 1 *, Jacqueline Müller-Nordhorn 2, Michael Böhmig 1,4, Stephanie Roll 2, Martin

More information

OPTIMISING OUTCOMES IN GASTROINTESTINAL NEUROENDOCRINE TUMOURS

OPTIMISING OUTCOMES IN GASTROINTESTINAL NEUROENDOCRINE TUMOURS OPTIMISING OUTCOMES IN GASTROINTESTINAL NEUROENDOCRINE TUMOURS Dr Mairéad McNamara Senior lecturer, University of Manchester & Honorary Consultant in Medical Oncology, The Christie NHS Foundation Trust

More information

symposium article Gastrointestinal neuroendocrine tumors K. E. Öberg* introduction and epidemiology diagnosis symposium article biochemical markers

symposium article Gastrointestinal neuroendocrine tumors K. E. Öberg* introduction and epidemiology diagnosis symposium article biochemical markers 21 (Supplement 7): vii72 vii80, 2010 doi:10.1093/annonc/mdq290 Gastrointestinal neuroendocrine tumors K. E. Öberg* Department of Endocrine Oncology, University Hospital, SE-751 85 Uppsala, Sweden Gastrointestinal

More information

ESSO Course on Diagnosis and Treatment of Pancreatic NeuroEndocrine Tumours (PNETs)

ESSO Course on Diagnosis and Treatment of Pancreatic NeuroEndocrine Tumours (PNETs) ESSO Course on Diagnosis and Treatment of Pancreatic NeuroEndocrine Tumours (PNETs) 26-27 May 2016 LONDON (UK) ESSO Course on Diagnosis and Management of Pancreatic Neuro-Endocrine Tumours (PNETs) Chairs

More information

Therapeutic Radiopharmaceuticals in Oncology

Therapeutic Radiopharmaceuticals in Oncology Therapeutic Radiopharmaceuticals in Oncology Policy Number: 6.01.60 Last Review: 9/2018 Origination: 9/2018 Next Review: 9/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage

More information

NET εντέρου Τι νεότερο/ Νέες μελέτες. Μαντώ Νικολαΐδη παθολόγος-ογκολόγος ΜΗΤΕΡΑ

NET εντέρου Τι νεότερο/ Νέες μελέτες. Μαντώ Νικολαΐδη παθολόγος-ογκολόγος ΜΗΤΕΡΑ NET εντέρου Τι νεότερο/ Νέες μελέτες Μαντώ Νικολαΐδη παθολόγος-ογκολόγος ΜΗΤΕΡΑ NET: A Diverse Group of Malignancies 1-3 Wide spectrum of malignancies arising in neuroendocrine cells throughout the body

More information

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GASTROINTESTINAL NEUROENDOCRINE GASTRO-ENTERO-PANCREATIC TUMOURS GI Site Group Neuroendocrine gastro-entero-pancreatic tumours Authors: Dr.

More information

9. Pharmacological therapy of neuroendocrine tumors

9. Pharmacological therapy of neuroendocrine tumors Tumori, 96: 847-857, 2010 9. Pharmacological therapy of neuroendocrine tumors Anja Rinke, Sergio Ricci, Emilio Bajetta, and Svetislav Jelic Evolving perspectives on antiproliferative effects of octreotide

More information

Gastrinoma: Medical Management. Haley Gallup

Gastrinoma: Medical Management. Haley Gallup Gastrinoma: Medical Management Haley Gallup Also known as When to put your knife down Gastrinoma Definition and History Diagnosis Historic Management Sporadic vs MEN-1 Defining surgical candidates Nonsurgical

More information

Research Article ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours

Research Article ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours ISRN Oncology Volume 2013, Article ID 420795, 7 pages http://dx.doi.org/10.1155/2013/420795 Research Article ENETS TNM Staging Predicts Prognosis in Small Bowel Neuroendocrine Tumours Rajaventhan Srirajaskanthan,

More information

Lu 177-Dotatate (Lutathera) Therapy Information

Lu 177-Dotatate (Lutathera) Therapy Information Lu 177-Dotatate (Lutathera) Therapy Information Information for Lu 177-dotatate therapy also known as Lutathera, for the treatment of metastatic midgut neuroendocrine tumor and other metastatic neuroendocrine

More information

SS2015 ANNUAL REGISTER AT SSO2015.ORG BY JANUARY 10 AND SAVE. March Houston, TX CANCER SYMPOSIUM #SSO2015TX

SS2015 ANNUAL REGISTER AT SSO2015.ORG BY JANUARY 10 AND SAVE. March Houston, TX CANCER SYMPOSIUM #SSO2015TX SS2015 ANNUAL CANCER SYMPOSIUM March 25-28 Houston, TX REGISTER AT SSO2015.ORG BY JANUARY 10 AND SAVE. #SSO2015TX JOIN THE TOP MINDS IN SURGICAL ONCOLOGY AT SSO 2015 On behalf of SSO President Ronald J.

More information

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms

ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms Consensus Guidelines Published online: January 19, 2016 Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms G. Delle Fave a D. O Toole b A. Sundin c B. Taal d P. Ferolla e J.K. Ramage

More information

Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours

Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours Original Article Page 1 of 7 Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours Roberta Elisa Rossi 1,2, Jorge Garcia-Hernandez 1, Tim Meyer 3, Christina Thirlwell

More information

GI CARCINOID Dr Mussawar Iqbal Consultant Oncologist Hull and East Yorkshire Hospitals NHS Trust

GI CARCINOID Dr Mussawar Iqbal Consultant Oncologist Hull and East Yorkshire Hospitals NHS Trust GI CARCINOID Dr Mussawar Iqbal Consultant Oncologist Hull and East Yorkshire Hospitals NHS Trust Introduction Carcinoid was old term, introduced in 1906 by German pathologist Cancinoma like More recent

More information

United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment

United States-based practice patterns and resource utilization in advanced neuroendocrine tumor treatment Online Submissions: http://www.wjgnet.com/esps/ wjg@wjgnet.com doi:10.3748/wjg.v19.i15.2348 World J Gastroenterol 2013 April 21; 19(15): 2348-2354 ISSN 1007-9327 (print) ISSN 2219-2840 (online) 2013 Baishideng.

More information

Sunitinib Achieved Fast and Sustained Control of VIPoma. Symptoms

Sunitinib Achieved Fast and Sustained Control of VIPoma. Symptoms Page 1 of 13 Accepted Preprint first posted on 10 October 2014 as Manuscript EJE-14-0682 1 1 Case report 2 3 4 Sunitinib Achieved Fast and Sustained Control of VIPoma Symptoms 5 6 7 Louis de Mestier 1,

More information

Letter from the Chairman

Letter from the Chairman Summer 2015 Letter from the Chairman Dear colleagues and friends, This last year has seen major changes within the structure and workings of ENETS as well as significant advances in our goals as a clinical

More information

A New Proposal for Metabolic Classification of NENs Stefano Severi IRST Meldola Italy

A New Proposal for Metabolic Classification of NENs Stefano Severi IRST Meldola Italy RADIONUCLIDE THERAPY AND ALLIED SCIENCE President: Giovanni Paganelli Chairman: Maria Salvato Baltimore USA Domenico Barone Meldola Italy A New Proposal for Metabolic Classification of NENs Stefano Severi

More information

Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin

Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin ENETS Guidelines DOI: 10.1159/000109976 Published online: October 16, 2007 Poorly-Differentiated Endocrine Carcinomas of Midgut and Hindgut Origin Hak an Ahlman a Ola Nilsson b Anne M. McNicol c Philippe

More information

Advanced typical and atypical carcinoid tumours of the lung: management recommendations

Advanced typical and atypical carcinoid tumours of the lung: management recommendations REVIEW ARTICLE Advanced typical and atypical carcinoid tumours of the lung: management recommendations B. Melosky md* ABSTRACT Background Neuroendocrine tumours (nets) are classified by site of origin,

More information

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation

ENETS Consensus Recommendations for the Standards of Care in Neuroendocrine Neoplasms: Follow-Up and Documentation Conference Report Neuroendocrinology 2017;105:310 319 Received: November 8, 2016 Accepted after revision: January 24, 2017 Published online: February 17, 2017 ENETS Consensus Recommendations for the Standards

More information

Consensus guidelines update for colorectal neuroendocrine

Consensus guidelines update for colorectal neuroendocrine Neuroendocrinology (DOI:10.1159/000443166) (Accepted, unedited article not yet assigned to an issue) Advanced Release: January 5, 2016 2016 S. Karger AG, Basel www.karger.com/nen Received: Accepted after

More information

Link and Lead A look in the future and the role of transplant coordinators.

Link and Lead A look in the future and the role of transplant coordinators. TRANSPLANTATION LEARNING JOURNEY Munich, Germany 6-10 2018 Second announcement 6-7 10 th ELITA 6-7 VCA 7 3 rd ETAHP 7-8 27 th 27 th Congress 3 rd Congress & Workshops Workshops 8 9-10 3 rd 9-10 Link and

More information

A Comprehensive Guide for 2014 SPONSORSHIP & UNDERWRITING Programs and Services

A Comprehensive Guide for 2014 SPONSORSHIP & UNDERWRITING Programs and Services A Comprehensive Guide for 2014 SPONSORSHIP & UNDERWRITING Programs and Services Sponsorship and Underwriting Programs and Services Mission to Care. Vision to Lead. There is no organization better positioned

More information

14th International Workshop Multiple Endocrine Neoplasia and other rare endocrine tumors. September 25 27, Vienna - Austria.

14th International Workshop Multiple Endocrine Neoplasia and other rare endocrine tumors. September 25 27, Vienna - Austria. 14th International Workshop Multiple Endocrine Neoplasia and other rare endocrine tumors September 25 27, 2014 Vienna - Austria Congress Venue Gesellschaft der Ärzte in Wien - Billrothhaus Frankgasse 8,

More information

Selection of Appropriate Treatment

Selection of Appropriate Treatment Expert Review in Metastatic Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): Selection of Appropriate Treatment Reference Slide Deck Neuroendocrine Tumors (NETs): A Diverse Group of Malignancies

More information

PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE

PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE PROVISIONAL SCIENTIFIC PROGRAMME AND TIMETABLE Thursday 17 th October, 2013 09.00- : Executive meetings (only for the Executive and the International Advisory Boards of EURIPA and the Executive of EGPRN),

More information

ENETS Aims & Key Dates... 5 Welcome Letter from the ENETS Chairman... 7 EACCME - UEMS Accreditation Statement

ENETS Aims & Key Dates... 5 Welcome Letter from the ENETS Chairman... 7 EACCME - UEMS Accreditation Statement XXXXXXXXX XXXXXXXX 2 Footnotes Table of Contents ENETS Aims & Key Dates... 5 Welcome Letter from the ENETS Chairman... 7 EACCME - UEMS Accreditation Statement 2018... 9 INTRODUCTION General Information...

More information

Neuroendocrine Tumors: Treatment Updates Highlights from the 2013 ASCO Annual Meeting. Chicago, IL, USA; May 30 - June 4, 2013

Neuroendocrine Tumors: Treatment Updates Highlights from the 2013 ASCO Annual Meeting. Chicago, IL, USA; May 30 - June 4, 2013 HIGHLIGHT ARTICLE Neuroendocrine Tumors: Treatment Updates Highlights from the 2013 ASCO Annual Meeting. Chicago, IL, USA; May 30 - June 4, 2013 Simon Khagi, Muhammad Wasif Saif Tufts Medical Center, Tufts

More information

PNET 3/7/2015. GI and Pancreatic NETs. The Postgraduate Course in Breast and Endocrine Surgery. Decision Tree. GI and Pancreatic NETs.

PNET 3/7/2015. GI and Pancreatic NETs. The Postgraduate Course in Breast and Endocrine Surgery. Decision Tree. GI and Pancreatic NETs. GI and Pancreatic NETs The Postgraduate Course in Breast and Endocrine Surgery Disclosures Ipsen NET Advisory Board Marines Memorial Club and Hotel San Francisco, CA Eric K Nakakura San Francisco, CA March

More information

Title: High Risk of Myelodysplastic Syndrome (MDS) and Acute Myeloid. in Neuroendocrine Tumor Patients Heavily Pre-treated with Alkylating

Title: High Risk of Myelodysplastic Syndrome (MDS) and Acute Myeloid. in Neuroendocrine Tumor Patients Heavily Pre-treated with Alkylating Page 1 of 12 Accepted Preprint first posted on 1 March 2016 as Manuscript ERC-15-0543 1 2 3 4 Title: High Risk of Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) after 177 Lu-octreotate

More information

NET und NEC. Endoscopic and oncologic therapy

NET und NEC. Endoscopic and oncologic therapy NET und NEC Endoscopic and oncologic therapy Classification well-differentiated NET - G1 and G2 - carcinoid poorly-differentiated NEC - G3 - like SCLC well differentiated NET G3 -> elevated proliferation

More information

Pancreatic Neuroendocrine Tumours

Pancreatic Neuroendocrine Tumours UCLH Cancer Collaborative Pancreas Update Meeting 12 th July 2017 Pancreatic Neuroendocrine Tumours Dr. Christos Toumpanakis MD PhD FRCP Consultant in Gastroenterology/Neuroendocrine Tumours Hon. Senior

More information

Disclosure of Relevant Financial Relationships

Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships USCAP requires that all faculty in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS

More information

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors The new england journal of medicine original article Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors Martyn E. Caplin, D.M., Marianne Pavel, M.D., Jarosław B. Ć wikła, M.D., Ph.D., Alexandria

More information

LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH

LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH LYON. FRANCE NOVEMBER 29-30 / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE https://events.easl.eu/eventportal/ Information/MLYON2013/HOME.aspx Abstract submission deadline:

More information

Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute

Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in Korea: A Clinicopathological Analysis of 72 Cases in a Single Institute pissn 1598-2998, eissn 25-9256 Cancer Res Treat. 215;47(4):738-746 Original Article http://dx.doi.org/1143/crt.214.224 Open Access Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases in

More information

QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors

QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors QOL Improvements in NETTER-1 Phase III Trial in Patients With Progressive Midgut Neuroendocrine Tumors Abstract C-33 Strosberg J, Wolin E, Chasen B, Kulke M, Bushnell D, Caplin M, Baum RP, Kunz P, Hobday

More information

Prolonged Survival in a Patient with Neuroendocrine Tumor of the Cecum and Diffuse Peritoneal Carcinomatosis

Prolonged Survival in a Patient with Neuroendocrine Tumor of the Cecum and Diffuse Peritoneal Carcinomatosis This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION Supplementary Table 1. Therapies for non-men1 pancreatic neuroendocrine tumours (NETs) (published after 2011) Somatostatin analogues Tumour type a Intervention Number of participants/information available

More information

Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study

Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study Zhang et al. BMC Endocrine Disorders 2014, 14:54 RESEARCH ARTICLE Open Access Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective

More information

ABSTRACT INTRODUCTION. Chaoyong Shen 1,*, Yuan Yin 1,*, Huijiao Chen 2, Sumin Tang 1, Xiaonan Yin 1, Zongguang Zhou 1,3, Bo Zhang 1, Zhixin Chen 1

ABSTRACT INTRODUCTION. Chaoyong Shen 1,*, Yuan Yin 1,*, Huijiao Chen 2, Sumin Tang 1, Xiaonan Yin 1, Zongguang Zhou 1,3, Bo Zhang 1, Zhixin Chen 1 /, 2017, Vol. 8, (No. 13), pp: 22123-22134 Neuroendocrine tumors of colon and rectum: validation of clinical and prognostic values of the World Health Organization 2010 grading classifications and European

More information

ESPACOMP SCIENTIFIC MEETING PROGRAM

ESPACOMP SCIENTIFIC MEETING PROGRAM Version 29.06.2018 SDG 22th ESPACOMP conference - Dublin, Ireland (European Society for Patient Adherence, COMpliance and Persiste nce) THURSDAY, NOVEMBER 29TH TO SATURDAY, DECEMBER 1ST, 2018 ESPACOMP

More information

Digestive and Liver Disease

Digestive and Liver Disease Digestive and Liver Disease 44 (2012) 95 105 Contents lists available at SciVerse ScienceDirect Digestive and Liver Disease journal homepage: www.elsevier.com/locate/dld Review Article New treatment strategies

More information

Management of Neuroendocrine Tumors

Management of Neuroendocrine Tumors Management of Neuroendocrine Tumors Professor Barbro Eriksson Department of Endocrine Oncology ENETS Centre of Excellence Uppsala University Hospital Diagnostic Challenges in NET Heterogeneous group of

More information

Let Your Education Soar Over the Land of Enchantment

Let Your Education Soar Over the Land of Enchantment SGNO Exhibitor Prospectus 2018 Albuquerque, New Mexico March 21 st -24th Let Your Education Soar Over the Land of Enchantment Nurse Oncologists The 35th Annual Symposium of the Society of Gynecologic Nurse

More information

Systemic Therapy for Advanced Pancreatic Neuroendocrine Tumors: An Update

Systemic Therapy for Advanced Pancreatic Neuroendocrine Tumors: An Update Focused Review 777 Systemic Therapy for Advanced Pancreatic Neuroendocrine Tumors: An Update Diane L. Reidy-Lagunes, MD, MS Abstract Well-differentiated neuroendocrine tumors (NETs) can be subdivided into

More information

Treatment algorithm Neuroendocrine tumours. Gregory Kaltsas Endocrine Unit, Department of Pathophysiology, University of Athens, Greece

Treatment algorithm Neuroendocrine tumours. Gregory Kaltsas Endocrine Unit, Department of Pathophysiology, University of Athens, Greece Treatment algorithm Neuroendocrine tumours Gregory Kaltsas Endocrine Unit, Department of Pathophysiology, University of Athens, Greece Outline Presenting a meaningful algorithm Means used to develop algorithm

More information

TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study

TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study DOI: 10.1093/jnci/djs208 Advance Access publication on April 23, 2012. The Author 2012. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

More information

Neuroendocrine Tumours If you don t suspect it you can t detect it! Dr JWS Devar HPB Surgeon University of Witwatersrand E-AHPBA CHBAH & WDGMC

Neuroendocrine Tumours If you don t suspect it you can t detect it! Dr JWS Devar HPB Surgeon University of Witwatersrand E-AHPBA CHBAH & WDGMC Neuroendocrine Tumours If you don t suspect it you can t detect it! Dr JWS Devar HPB Surgeon University of Witwatersrand E-AHPBA CHBAH & WDGMC Case Study 43 yr old female with a history of a left mastectomy

More information

NET ΠΝΕΥΜΟΝΑ: τι νεότερο / νέες μελέτες

NET ΠΝΕΥΜΟΝΑ: τι νεότερο / νέες μελέτες NETMASTERCLASS 2017: an interactive workshop NET ΠΝΕΥΜΟΝΑ: τι νεότερο / νέες μελέτες Νικόλαος Τσουκαλάς MD, MSc, PhD Ογκολόγος - Παθολόγος, MSc Βιοπληροφορική Επιμελητής Α, Ογκολογικό Τμήμα Νοσηλευτικό

More information

Case Report. Ameya D. Puranik, MD, FEBNM; Harshad R. Kulkarni, MD; Aviral Singh, MD; Richard P. Baum, MD, PhD ABSTRACT

Case Report. Ameya D. Puranik, MD, FEBNM; Harshad R. Kulkarni, MD; Aviral Singh, MD; Richard P. Baum, MD, PhD ABSTRACT Case Report 8-YEAR SURVIVAL WITH A METASTATIC THYMIC NEUROENDOCRINE TUMOR: EMPHASIS ON REDEFINING TREATMENT OBJECTIVES USING PERSONALIZED PEPTIDE RECEPTOR RADIONUCLIDE THERAPY WITH 177 Lu- AND 90 Y-LABELED

More information

NEUROENDOCRINE TUMOURS Updated December 2015 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary)

NEUROENDOCRINE TUMOURS Updated December 2015 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary) NEUROENDOCRINE TUMOURS Updated December 2015 by Dr. Doreen Ezeife (PGY-5 Medical Oncology Resident, University of Calgary) Reviewed by Dr. Cynthia Card (Staff Medical Oncologist, University of Calgary)

More information

LABORATORY ANIMAL SCIENCE ASSOCIATION. Information Booklet

LABORATORY ANIMAL SCIENCE ASSOCIATION. Information Booklet LABORATORY ANIMAL SCIENCE ASSOCIATION Information Booklet Platinum Sponsor: Gold Sponsors: Silver Sponsors: Bronze Sponsors: Welcome! We are pleased to invite you to Birmingham for the 2017 LASA Annual

More information

Nuevas alternativas en el manejo de TNE avanzados

Nuevas alternativas en el manejo de TNE avanzados Nuevas alternativas en el manejo de TNE avanzados Jaume Capdevila Hospital Universitari Vall d Hebron Barcelona Coordinación científica: Dr. Fernando Rivera Hospital Universitario Marqués de Valdecilla,

More information

Conference on Philanthropy 2019: Responsive Philanthropy

Conference on Philanthropy 2019: Responsive Philanthropy Conference on Philanthropy 2019: Responsive Philanthropy May 22-24, 2019 Washington Marriott at Metro Center Washington, DC The International Association of Advisors in Philanthropy (AiP) is proud to present

More information

13 th Congress of the European Hip Society

13 th Congress of the European Hip Society 13 th Congress of the European Hip Society Congress President: Dr. Berend Willem Schreurs, Nijmegen CALL FOR ABSTRACTS 20 22 September 2018 The Hague, The Netherlands www.ehs-congress.org 13 th Congress

More information

Infos:

Infos: SPRING MEETING SWISS SOCIETY OF PHARMACOLOGY & TOXICOLOGY Pharmacology and Toxicology of Ageing: Integrating education from basic research to clinical science April 19, 2012 Inselspital Bern Infos: http://www.swisspharmtox.ch

More information

Practical management and treatment of pancreatic neuroendocrine tumors

Practical management and treatment of pancreatic neuroendocrine tumors Review Article Practical management and treatment of pancreatic neuroendocrine tumors Naoko Iwahashi Kondo, Yasuharu Ikeda Department of Gastroenterological Surgery, National Hospital Organization Kyushu

More information

oncology For 9 th eso-esmo course on July 2012 ioannina, Greece

oncology For 9 th eso-esmo course on July 2012 ioannina, Greece ESO ADVANCED COURSES, SEMINARS AND SYMPOSIA ioannina 21/07/12 9 th eso-esmo course on oncology For medical students 21-27 July 2012 ioannina, Greece chair: N. Pavlidis, GR core faculty: R.A. Audisio, UK

More information

Chromogranin A as a Marker for Diagnosis, Treatment, and Survival in Patients With Gastroenteropancreatic Neuroendocrine Neoplasm

Chromogranin A as a Marker for Diagnosis, Treatment, and Survival in Patients With Gastroenteropancreatic Neuroendocrine Neoplasm Chromogranin A as a Marker for Diagnosis, Treatment, and Survival in Patients With Gastroenteropancreatic Neuroendocrine Neoplasm Yu-hong Wang, PhD, Qiu-chen Yang, MD, Yuan Lin, MD, PhD, Ling Xue, MD,

More information

ESPE Science School (ESS) May 16-20, Heraklio, Crete, Greece

ESPE Science School (ESS) May 16-20, Heraklio, Crete, Greece ESPE Science School (ESS) May 16-20, 2012 - Heraklio, Crete, Greece November 27, 2011 Dear ESPE member, RE: Call for ESS Student applications This is our annual call for ESPE members to have their younger

More information